FR241M - Compositions antihypercholestérolémiques. - Google Patents

Compositions antihypercholestérolémiques.

Info

Publication number
FR241M
FR241M FR825248A FR825248A FR241M FR 241 M FR241 M FR 241M FR 825248 A FR825248 A FR 825248A FR 825248 A FR825248 A FR 825248A FR 241 M FR241 M FR 241M
Authority
FR
France
Prior art keywords
antihypercholesterolemic
compositions
antihypercholesterolemic compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR825248A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Application granted granted Critical
Publication of FR241M publication Critical patent/FR241M/fr
Active legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR825248A 1959-05-01 1960-07-23 Compositions antihypercholestérolémiques. Active FR241M (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US810213A US3157574A (en) 1959-05-01 1959-05-01 Method of reducing cholesterol levels

Publications (1)

Publication Number Publication Date
FR241M true FR241M (fr) 1961-03-06

Family

ID=25203275

Family Applications (1)

Application Number Title Priority Date Filing Date
FR825248A Active FR241M (fr) 1959-05-01 1960-07-23 Compositions antihypercholestérolémiques.

Country Status (4)

Country Link
US (1) US3157574A (fr)
BE (1) BE589856A (fr)
FR (1) FR241M (fr)
GB (1) GB923171A (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3855405A (en) * 1969-11-26 1974-12-17 Squibb & Sons Inc Radiographic contrast composition containing 2{40 ,6{40 -diiodo-dl-thyronine and methods of use thereof
DE2126533A1 (de) * 1971-05-28 1972-12-14 Merck Patent Gmbh, 6100 Darmstadt Verfahren zur Herstellung pharma zeutischer Zubereitungen
GB9401891D0 (en) 1994-02-01 1994-03-30 Boots Co Plc Therapeutic agents
GB9401892D0 (en) * 1994-02-01 1994-03-30 Boots Co Plc Therapeutic agents
ITMI20011401A1 (it) * 2001-07-02 2003-01-02 Altergon Sa Formulazioni farmaceutiche per ormoni tiroidei

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2823164A (en) * 1953-02-25 1958-02-11 Nat Res Dev Method of preparing 3, 5, 3' l-tri-iodothyronine and pharmaceutical compositions thereof
US2925364A (en) * 1957-08-12 1960-02-16 Baxter Laboratories Inc Method of treating hypercholesterol-emia with d-thyroxine

Also Published As

Publication number Publication date
US3157574A (en) 1964-11-17
BE589856A (fr) 1960-08-16
GB923171A (en) 1963-04-10

Similar Documents

Publication Publication Date Title
BE594893A (fr) Compositions antibiotiques.
FR369M (fr) Halogénotétracyclines.
BE585839A (fr) Compositions anti-deprimantes.
BE596003A (fr) Amino-hydroxy-nitriles.
FR241M (fr) Compositions antihypercholestérolémiques.
BE587834A (fr) Compositions de polissage.
BE596216A (nl) Gesubstitueerde 2-imidazolidinethionen.
DK103424C (da) Høvender.
DK120015B (da) Fluidistor.
BE595070A (fr) Plansichter.
FR17M (fr) Compositions antibiotiques améliorées.
FR343M (fr) Compositions antibiotiques.
DK95557C (da) Glashus.
BE595049A (fr) Compositions de revêtement.
BE593379A (fr) Composition retardatrice.
FR262M (fr) Nitrothiazolyl-pipérazines substituées.
BE590424A (fr) Compositions hormonales.
GR22014B (el) Θειολοκαρβαμικαι ενωσεις.
DK94695C (da) Mejetærsker.
FR33M (fr) 3-méthoxy-2-sulfanilamidopyrazine.
FR288M (fr) Trifluorométhylphénylalcoylamines.
DK101446C (da) Høvender.
DK100531C (da) Paraciticid.
DK93858C (da) Getterholder.
DK92820C (da) Nematodicid.